Lv5
980 积分 2023-04-25 加入
Adebrelimab versus serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China
22小时前
待确认
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
22小时前
已完结
Phase I Studies of HLX26, A Novel Anti-LAG-3 Antibody, Monotherapy or Combination Therapy in Patients with Advanced Solid Tumors
13天前
已关闭
Adherence to medication
1个月前
已完结
Distinguishing features of a novel humanized anti-EGFR monoclonal antibody based on cetuximab with superior antitumor efficacy
1个月前
已完结
Lecanemab in Early Alzheimer’s Disease
3个月前
已完结
Incidence and prevalence of Alzheimer’s disease in China: a systematic review and meta-analysis
3个月前
已完结
Alzheimer disease
3个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
3个月前
已完结
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
4个月前
已完结
皖公网安备34019202002308
